揭示囊性纤维化相关糖尿病的发育起源
本文综述囊性纤维化相关糖尿病(CFRD)的发育起源假说,指出CF患者早在宫内即出现胰腺病理和血糖异常,提示CFTR基因突变可能损害胰腺器官发生并导致CFRD。文章汇总CFTR在胰腺内分泌、外分泌及胰岛微环境发育中作用的现有证据,强调阐明CFRD发病机制可能改变未来诊疗方式。
要点
- CFRD是CF患者日益突出的独特临床实体,其病理生理仍不明确。
- CF患者宫内即可出现胰腺病理和血糖异常,支持发育起源假说。
- CFTR突变可能通过损害胰腺器官发生参与CFRD发生。
核心结论
- CFRD可能具有发育起源,CFTR突变或通过损害胰腺器官发生导致该病。
研究设计与样本
- 综述,检索并汇总支持CFTR在胰腺发育中起关键作用的现有证据。
主要发现
- CF患者早在宫内即出现胰腺病理和血糖异常。
- CFTR在胰腺内分泌、外分泌及胰岛微环境的器官发生中可能发挥重要作用。
临床怎么用
- 深入理解CFRD发病机制可能改变未来照护方式,但本文未给出具体诊疗推荐。
局限性
- CFRD病理生理和发病机制的许多方面仍不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cystic fibrosis (CF)-related diabetes (CFRD) is a growing and evolving concern for people living with cystic fibrosis. As its own unique clinical entity, there is an urgent need to better understand this complex health challenge to improve the quality of life for people with CF. Unfortunately, many aspects of CFRD pathophysiology and pathogenesis remain unclear, resulting in a disparity in the standard of care provided. An emerging body of evidence supports that CFRD may have developmental origins, as people with CF present with pancreatic pathology and glucose abnormalities as early as in utero. This therefore suggests that the CF transmembrane conductance regulator (CFTR) gene mutations that cause CF may impair pancreatic organogenesis, thus leading to CFRD. This review consequently aims to summarise the existing evidence that may support a fundamentally vital role of CFTR in the development of the pancreas. From aspects of the endocrine and exocrine pancreas to scrutinising the broader islet microenvironment, the many constituents at play in pancreatic organogenesis are highlighted. Unravelling the deeper complexities of CFRD pathogenesis will not only clarify existing knowledge gaps but may transform the way future care is provided.
引用
- Cho A, Nostro MC. Unravelling the developmental origins of cystic fibrosis-related diabetes. Diabetologia. 2026. PMID: 42262528. doi:10.1007/s00125-026-06768-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。